Cite Filings / ACAD / 0000950170-23-015972

Feed Companies Filings Check

Sign in

ARS

Annual Report to Security Holders

ACADIA PHARMACEUTICALS INC Filed 2023-05-01 Acc 0000950170-23-015972

Documents 1

ARS Annual Report to Security Holders , acad_2022_annual_report.pdf

Around this filing

2024-04-26 ARS Annual Report to Security Holders
2023-05-02 4 EVP,General Counsel, Secretary sold 917 shares at $21.18 ($19,422)
2023-05-02 4 EVP, COO, Head of Commercial sold 548 shares at $21.18 ($11,607)
2023-05-02 4 CEO sold 7,806 shares at $21.18 ($165,331)
2023-05-01 ARS Annual Report to Security Holders
2023-05-01 DEF 14A Proxy Statement
2014-04-25 ARS Annual Report to Security Holders

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading acad_2022_annual_report.pdf…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…